Statement Of Financial Position [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166255

Concept	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2022-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2021-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31	As at 2020-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment	176,000 EUR	—	—	—	—	—	—	—	—	122,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Intangible assets other than goodwill	3,607,000 EUR	—	—	—	—	—	—	—	—	2,944,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Investments accounted for using equity method	3,948,000 EUR	—	—	—	—	—	—	—	—	4,079,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Cash and cash equivalents	43,457,000 EUR	—	—	—	—	—	—	—	—	50,012,000 EUR	—	—	—	—	—	—	—	—	—	—	64,399,000 EUR
Assets	61,864,000 EUR	—	—	—	—	—	—	—	—	63,444,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities [abstract]
Equity [abstract]
Issued capital	140,000 EUR	—	—	—	—	—	—	—	—	129,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Retained earnings	53,476,000 EUR	—	—	—	—	—	—	—	—	43,226,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Share premium	121,513,000 EUR	—	—	—	—	—	—	—	—	103,693,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Other reserves	476,000 EUR	—	—	—	—	—	—	—	—	476,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity	55,045,000 EUR	476,000 EUR	121,513,000 EUR	1,622,000 EUR	64,246,000 EUR	140,000 EUR	4,460,000 EUR	54,805,000 EUR	476,000 EUR	48,056,000 EUR	3,827,000 EUR	103,693,000 EUR	2,391,000 EUR	129,000 EUR	43,226,000 EUR	129,000 EUR	3,827,000 EUR	476,000 EUR	1,814,000 EUR	103,693,000 EUR	59,059,000 EUR
Liabilities [abstract]
Liabilities	6,819,000 EUR	—	—	—	—	—	—	—	—	15,388,000 EUR	—	—	—	—	—	—	—	—	—	—	—
Equity and liabilities	61,864,000 EUR	—	—	—	—	—	—	—	—	63,444,000 EUR	—	—	—	—	—	—	—	—	—	—	—